Determination of metal residues in active pharmaceutical ingredients according to European current legislation by using X-ray fluorescence spectrometry

Journal of Analytical Atomic Spectrometry

Volumn 24, Issue 9, 2009, Pages 1253-1257

  Margui E ^a   Fontas C ^b   Buendia A ^c   Hidalgo, M ^b   Queralt, I ^a  

^a INSTITUTE OF EARTH SCIENCES JAUME ALMERA   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

^c Medichem   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; ANALYTICAL TECHNIQUES; CALIBRATION STANDARD; DRUG SUBSTANCES; EUROPEAN AGENCY; HUMAN USE; INORGANIC IMPURITIES; INTERNATIONAL CONFERENCE ON HARMONIZATIONS; MATRIX; MEDICINAL PRODUCTS; METAL RESIDUES; SIMPLE METHOD; SPECIFICATION LIMIT; TECHNICAL REQUIREMENT; WAVELENGTH-DISPERSIVE X-RAY FLUORESCENCES; X RAY FLUORESCENCE SPECTROMETRY; XRF SPECTROMETRY;

CHROMIUM; DRUG PRODUCTS; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; HEAVY METALS; METALS; SPECTROMETRY; ZINC;

SYNTHETIC METALS;

EID: 69149110276     PISSN: 02679477     EISSN: 13645544     Source Type: Journal    
DOI: 10.1039/b904064a     Document Type: Conference Paper

References (16)

1. R. Nagaswara Rao M. V. N. Kumar Talluri Journal of Pharmaceutical and Biomedical Analysis 2007 43 1 13
2. J. Kemsley, Improving metal detection in drugs, C&EN West Coast News Bureau, American Chemical Society, Washington, USA, 2008, pp. 32-34
3. The United States Pharmacopoeia, USP30. Chemical Tests. Limit Tests. <231> Heavy metals, pp. 146-147
4. European Pharmacopoeia, 5.2 Analytical Methods, Date of Implementation 2005, pp. 103-105
5. British Pharmacopoeia, Appendix, Norwich, UK, 2000, pp. A174-176
6. Japanese Pharmacopoeia, Method 22, XIV edn, Part I, pp. 43-44
7. Guideline on the specification limits for residues of metal catalysts or metal reagents, (Doc.Ref. EMEA/CHMP/SWP/4446/2000). Committee for medicinal products for human use (CHMP). European Medicines Agency, London, February 2008, pp. 1-34
8. N. Lewen S. Mathew M. Schenkenberger T. Raglione Journal of Pharmaceutical and Biomedical Analysis 2004 35 739 752
9. The United States Pharmacopoeia (USP) Pharmacopoeial Forum 2008 34 1345
10. X. Jia T. Wang J. Wu Journal of Pharmaceutical and Biomedical Analysis 2001 54 741 751
11. E. Marguí C. Fontàs K. Van Meel R. Van Grieken I. Queralt M. Hidalgo Anal. Chem. 2008 80 1357 1364
12. L. Perring D. Andrey X-Ray Spectrom. 2004 33 128 135
13. E. Marguí K. Van Meel R. Van Grieken A. Buendía C. Fontàs M. Hidalgo I. Queralt Anal Chem. 2009 81 1404 1410
14. " Validation of analytical procedures: Text and Methodology Q2(R1) ". International conference on harmonization of technical requirements for registration of pharmaceuticals for human use (ICH), November 2005
15. http://www.bruker-axs.de
16. R. E. Van Grieken, A. A. Markowicz, (eds) in " Handbook of X-Ray Spectrometry. Methods and Techniques ", Marcel Dekker, Inc., New York, 1993